These results suggest that exposure to HBOT significantly decreases iNOS activity/expression and indicate that ERK1/2 and Akt are involved in HBOT-downregulated iNOS activity/expression in T1DM patients. This evidence concerns the gene AKT1 and type 1 diabetes mellitus.